The DOI matches its Crossref record; 123 of the 123 references it cites were found in a registry or an index.
Antibody‐Conjugated Nanoparticles for Biomedical Applications
Open accessAbstract
Nanoscience and Nanotechnology have found their way into the fields of Biotechnology and Medicine. Nanoparticles by themselves offer specific physicochemical properties that they do not exhibit in bulk form, where materials show constant physical properties regardless of size. Antibodies are nanosize biological products that are part of the specific immune system. In addition to their own properties as pathogens or toxin neutralizers, as well as in the recruitment of immune elements (complement, improving phagocytosis, cytotoxicity antibody dependent by natural killer cells, etc.), they could carry several elements (toxins, drugs, fluorochroms, or even nanoparticles, etc.) and be used in several diagnostic procedures, or even in therapy to destroy a specific target. The conjugation of antibodies to nanoparticles can generate a product that combines the properties of both. For example, they can combine the small size of nanoparticles and their special thermal, imaging, drug carrier, or magnetic characteristics with the abilities of antibodies, such as specific and selective recognition. The hybrid product will show versatility and specificity. In this review, we analyse both antibodies and nanoparticles, focusing especially on the recent developments for antibody‐conjugated nanoparticles, offering the researcher an overview of the different applications and possibilities of these hybrid carriers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance
Hirsch, L. R., Stafford, R. J., Bankson, J. A., Sershen, S. R., Rivera, B., Price, R. E., Hazle, J. D., Halas, N. J., & West, J. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2232479100 · Cited by 3,955
Naturally occurring antibodies devoid of light chains
Hamers-Casterman, C., Atarhouch, T., Muyldermans, S., Robinson, G., Hammers, C., Songa, E. B., Bendahman, N., & Hammers, R. (1993) · Nature · doi:10.1038/363446a0 · Cited by 3,241 · cited 1×
“The presence of antibody molecules composed of heavy chain dimers devoid of the light chain was discovered in camel blood [55, 56].”
BackgroundRegulation of transport pathways in tumor vessels: Role of tumor type and microenvironment
Hobbs, S. K., Monsky, W. L., Yuan, F., Roberts, W. G., Griffith, L., Torchilin, V. P., & Jain, R. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4607 · Cited by 2,438
Phage antibodies: filamentous phage displaying antibody variable domains
McCafferty, J., Griffiths, A. D., Winter, G., & Chiswell, D. J. (1990) · Nature · doi:10.1038/348552a0 · Cited by 2,423
Scanometric DNA Array Detection with Nanoparticle Probes
Taton, T. A., Mirkin, C. A., & Letsinger, R. L. (2000) · Science · doi:10.1126/science.289.5485.1757 · Cited by 2,411
A simplified method for cyanogen bromide activation of agarose for affinity chromatography
March, S. C., Parikh, I., & Cuatrecasas, P. (1974) · Analytical Biochemistry · doi:10.1016/0003-2697(74)90139-0 · Cited by 1,935
El-Sayed, I. H., Huang, X., & El-Sayed, M. A. (2005) · Nano Letters · doi:10.1021/nl050074e · Cited by 1,919
Magnetic nanoparticles for drug delivery
Arruebo, M., Fernández-Pacheco, R., Ibarra, M. R., & Santamaría, J. (2007) · Nano Today · doi:10.1016/s1748-0132(07)70084-1 · Cited by 1,613
Self-citationHuston, J. S., Levinson, D., Mudgett-Hunter, M., Tai, M. S., Novotný, J., Margolies, M. N., Ridge, R. J., Bruccoleri, R. E., Haber, E., & Crea, R. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.16.5879 · Cited by 1,593
Single-Chain Antigen-Binding Proteins
Bird, R. E., Hardman, K. D., Jacobson, J. W., Johnson, S., Kaufman, B. M., Lee, S.-M., Lee, T., Pope, S. H., Riordan, G. S., & Whitlow, M. (1988) · Science · doi:10.1126/science.3140379 · Cited by 1,502
McCune, J., Namikawa, R., Kaneshima, H., Shultz, L., Lieberman, M., & Weissman, I. (1988) · Science · doi:10.1126/science.241.4873.1632 · Cited by 1,406
ELSAYED, I., HUANG, X., & ELSAYED, M. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.07.035 · Cited by 1,354
Transfer of a functional human immune system to mice with severe combined immunodeficiency
Mosier, D. E., Gulizia, R. J., Baird, S. M., & Wilson, D. B. (1988) · Nature · doi:10.1038/335256a0 · Cited by 1,255
Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains.
Morrison, S. L., Johnson, M. J., Herzenberg, L. A., & Oi, V. T. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.21.6851 · Cited by 1,039
Vaughan, T. J., Williams, A. J., Pritchard, K., Osbourn, J. K., Pope, A. R., Earnshaw, J. C., McCafferty, J., Hodits, R. A., Wilton, J., & Johnson, K. S. (1996) · Nature Biotechnology · doi:10.1038/nbt0396-309 · Cited by 1,027
Yguerabide, J., & Yguerabide, E. E. (1998) · Analytical Biochemistry · doi:10.1006/abio.1998.2759 · Cited by 889
(1990) · Biochemical Education · doi:10.1016/0307-4412(90)90028-m · Cited by 882
"Diabodies": small bivalent and bispecific antibody fragments.
Holliger, P., Prospero, T., & Winter, G. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.14.6444 · Cited by 874
Transport of molecules across tumor vasculature
Jain, R. K. (1987) · CANCER AND METASTASIS REVIEW · doi:10.1007/bf00047468 · Cited by 866
Sokolov, K., Follen, M. M., Aaron, J., Pavlova, I., Malpica, A. L., Lotan, R., & Richards-Kortum, R. R. (2003) · PubMed · Cited by 838
A biosensor based on magnetoresistance technology
Baselt, D. R., Lee, G. U., Natesan, M., Metzger, S. W., Sheehan, P. E., & Colton, R. J. (1998) · Biosensors and Bioelectronics · doi:10.1016/s0956-5663(98)00037-2 · Cited by 823
Antibodies to Bradykinin and Angiotensin: A Use of Carbodiimides in Immunology
Goodfriend, T. L., Levine, L., & Fasman, G. D. (1964) · Science · doi:10.1126/science.144.3624.1344 · Cited by 807
Generation of a Large Combinatorial Library of the Immunoglobulin Repertoire in Phage Lambda
Huse, W. D., Sastry, L., Iverson, S. A., Kang, A. S., Alting-Mees, M., Burton, D. R., Benkovic, S. J., & Lerner, R. A. (1989) · Science · doi:10.1126/science.2531466 · Cited by 805
A Whole Blood Immunoassay Using Gold Nanoshells
Hirsch, L. R., Jackson, J. B., Lee, A., Halas, N. J., & West, J. L. (2003) · Analytical Chemistry · doi:10.1021/ac0262210 · Cited by 676
Liu, X., Dai, Q., Austin, L., Coutts, J., Knowles, G., Zou, J., Chen, H., & Huo, Q. (2008) · Journal of the American Chemical Society · doi:10.1021/ja711298b · Cited by 675
Zharov, V. P., Mercer, K. E., Galitovskaya, E. N., & Smeltzer, M. S. (2006) · Biophysical Journal · doi:10.1529/biophysj.105.061895 · Cited by 567
Production of functional chimaeric mouse/human antibody
Boulianne, G. L., Hozumi, N., & Shulman, M. J. (1984) · Nature · doi:10.1038/312643a0 · Cited by 550
Mouse/human chimeric monoclonal antibody in man: kinetics and immune response.
LoBuglio, A. F., Wheeler, R. H., Trang, J., Haynes, A., Rogers, K., Harvey, E. B., Sun, L., Ghrayeb, J., & Khazaeli, M. B. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.11.4220 · Cited by 524
Perez, J. M., Simeone, F. J., Saeki, Y., Josephson, L., & Weissleder, R. (2003) · Journal of the American Chemical Society · doi:10.1021/ja036409g · Cited by 517
Engraftment of Immune-Deficient Mice with Human Hematopoietic Stem Cells
Kamel-Reid, S., & Dick, J. E. (1988) · Science · doi:10.1126/science.2904703 · Cited by 455
DNA packaging by the double-stranded DNA bacteriophages
Earnshaw, W. C., & Casjens, S. (1980) · Cell · doi:10.1016/0092-8674(80)90468-7 · Cited by 441
Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody
Kocbek, P., Obermajer, N., Cegnar, M., Kos, J., & Kristl, J. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.03.012 · Cited by 436
Ultrasensitive magnetic biosensor for homogeneous immunoassay
Chemla, Y. R., Grossman, H. L., Poon, Y., McDermott, R., Stevens, R., Alper, M. D., & Clarke, J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.26.14268 · Cited by 421
Kumar, S., Aaron, J., & Sokolov, K. (2008) · Nature Protocols · doi:10.1038/nprot.2008.1 · Cited by 411
Antigen-specific human antibodies from mice comprising four distinct genetic modifications
Lonberg, N., Taylor, L. D., Harding, F. A., Trounstine, M., Higgins, K. M., Schramm, S. R., Kuo, C.-C., Mashayekh, R., Wymore, K., McCabe, J. G., et al. (1994) · Nature · doi:10.1038/368856a0 · Cited by 398
Heidel, J. D., Yu, Z., Liu, J. Y.-C., Rele, S. M., Liang, Y., Zeidan, R. K., Kornbrust, D. J., & Davis, M. E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701458104 · Cited by 382
Current methods for attaching targeting ligands to liposomes and nanoparticles
Nobs, L., Buchegger, F., Gurny, R., & Allémann, E. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20098 · Cited by 379
Mach, J.-P., Buchegger, F., Forni, M., Ritschard, J., Berche, C., Lumbroso, J.-D., Schreyer, M., Girardet, C., Accolla, R. S., & Carrel, S. (1981) · Immunology Today · doi:10.1016/0167-5699(81)90011-6 · Cited by 376
Reshaping Human Antibodies: Grafting an Antilysozyme Activity
Verhoeyen, M., Milstein, C., & Winter, G. (1988) · Science · doi:10.1126/science.2451287 · Cited by 345
Hu, S., Shively, L., Raubitschek, A. A., Sherman, M. A., Williams, L. E., Wong, J. Y., Shively, J. E., & Wu, A. M. (1996) · PubMed · Cited by 330
Cui, Y., Ren, B., Yao, J.-L., Gu, R.-A., & Tian, Z.-Q. (2006) · The Journal of Physical Chemistry B · doi:10.1021/jp056203x · Cited by 312
Clinical trials of antibody therapy
Glennie, M. J., & Johnson, P. W. M. (2000) · Immunology Today · doi:10.1016/s0167-5699(00)01669-8 · Cited by 288
Sun, B., Ranganathan, B., & Feng, S.-S. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2007.09.038 · Cited by 274
Evolution of proteins formed by β-sheets
Lesk, A. M., & Chothia, C. (1982) · Journal of Molecular Biology · doi:10.1016/0022-2836(82)90179-6 · Cited by 273
Glennie, M. J., McBride, H. M., Worth, A. T., & Stevenson, G. T. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.7.2367 · Cited by 263
Nanobiohybrids as delivery vehicles for camptothecin
Tyner, K. M., Schiffman, S. R., & Giannelis, E. P. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.12.027 · Cited by 262
Targeted drug conjugates: principles and progress
Garnett, M. C. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00227-7 · Cited by 262
Brennan, M., Davison, P. F., & Paulus, H. (1985) · Science · doi:10.1126/science.3925553 · Cited by 251
Tissue-specific MR contrast agents
Weinmann, H.-J., Ebert, W., Misselwitz, B., & Schmitt-Willich, H. (2003) · European Journal of Radiology · doi:10.1016/s0720-048x(02)00332-7 · Cited by 250
Amidi, M., Romeijn, S. G., Verhoef, J. C., Junginger, H. E., Bungener, L., Huckriede, A., Crommelin, D. J. A., & Jiskoot, W. (2007) · Vaccine · doi:10.1016/j.vaccine.2006.06.086 · Cited by 247
Haes, A. J., Stuart, D. A., Nie, S., & Van Duyne, R. P. (2004) · Journal of Fluorescence · doi:10.1023/b:jofl.0000031817.35049.1f · Cited by 245
Selective targeting of antibody-conjugated nanoparticles to leukemic cells and primary T-lymphocytes
Dinauer, N., Balthasar, S., Weber, C., Kreuter, J., Langer, K., & von Briesen, H. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2005.02.038 · Cited by 234
Multiphoton plasmon-resonance microscopy
Yelin, D., Oron, D., Thiberge, S., Moses, E., & Silberberg, Y. (2003) · Optics Express · doi:10.1364/oe.11.001385 · Cited by 232
Green, L. L. (1999) · Journal of Immunological Methods · doi:10.1016/s0022-1759(99)00137-4 · Cited by 229 · cited 1×
“This type of mouse is known as XenoMouse and has human immunoglobulin transgenes containing a large part of the V gene repertoire in the terminal line, which supports the development of a large population of B lymphocytes and the formation of a broad and diverse primary immune repertoire, secreting human antibodies [6…”
BackgroundProduction of human monoclonal antibody in eggs of chimeric chickens
Zhu, L., van de Lavoir, M.-C., Albanese, J., Beenhouwer, D. O., Cardarelli, P. M., Cuison, S., Deng, D. F., Deshpande, S., Diamond, J. H., Green, L., et al. (2005) · Nature Biotechnology · doi:10.1038/nbt1132 · Cited by 222
Pharmaceutical applications of magnetic resonance imaging (MRI)
RICHARDSON, J., BOWTELL, R., MADER, K., & MELIA, C. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.01.024 · Cited by 220
Phage display of combinatorial antibody libraries
Rader, C., & Barbas, C. F. (1997) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(97)80075-4 · Cited by 220
Sung Kim, K., & Park, J.-K. (2005) · Lab on a Chip · doi:10.1039/b502225h · Cited by 217
Trastuzumab-modified nanoparticles: Optimisation of preparation and uptake in cancer cells
Steinhauser, I., Spänkuch, B., Strebhardt, K., & Langer, K. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.05.016 · Cited by 216
Highly Specific HER2-mediated Cellular Uptake of Antibody-modified Nanoparticles in Tumour Cells
Wartlick, H., Michaelis, K., Balthasar, S., Strebhardt, K., Kreuter, J., & Langer, K. (2004) · Journal of Drug Targeting · doi:10.1080/10611860400010697 · Cited by 211
DeNardo, S. J., DeNardo, G. L., Miers, L. A., Natarajan, A., Foreman, A. R., Gruettner, C., Adamson, G. N., & Ivkov, R. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1004-0022 · Cited by 200
Kabat, E. A., Wu, T. T., & Bilofsky, H. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)39891-5 · Cited by 199
The immunogenicity of chimeric antibodies.
Brüggemann, M., Winter, G., Waldmann, H., & Neuberger, M. S. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.6.2153 · Cited by 178
Coloma, M. J., Hastings, A., Wims, L. A., & Morrison, S. L. (1992) · Journal of Immunological Methods · doi:10.1016/0022-1759(92)90092-8 · Cited by 176
In Vivo Imaging of Activated Endothelium Using an Anti-VCAM-1 Magnetooptical Probe
Tsourkas, A., Shinde-Patil, V. R., Kelly, K. A., Patel, P., Wolley, A., Allport, J. R., & Weissleder, R. (2005) · Bioconjugate Chemistry · doi:10.1021/bc050002e · Cited by 171
Padlan, E. A. (1991) · Molecular Immunology · doi:10.1016/0161-5890(91)90163-e · Cited by 169
Hall, J. F. (1998) · Biochemical Education · doi:10.1016/s0307-4412(98)00067-3 · Cited by 168
Cheng, W. W. K., & Allen, T. M. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.11.005 · Cited by 159
Building Antibodies from their Genes
Hoogenboom, H. R., Marks, J. D., Riffiths, A. D. G., & Winter, G. P. (1992) · Immunological Reviews · doi:10.1111/j.1600-065x.1992.tb01520.x · Cited by 141
Antibody VH Domains as Small Recognition Units
Davies, J., & Riechmann, L. (1995) · Nature Biotechnology · doi:10.1038/nbt0595-475 · Cited by 140
Photokilling cancer cells using highly cell-specific antibody–TiO2 bioconjugates and electroporation
Xu, J., Sun, Y. E., Huang, J., Chen, C., Liu, G., Jiang, Y., Zhao, Y., & Jiang, Z. (2007) · Bioelectrochemistry · doi:10.1016/j.bioelechem.2007.06.001 · Cited by 140
Kortt, A. A., Lah, M. S., Oddie, G. W., Gruen, C. L., Burns, J. E., Pearce, L. A., Atwell, J. L., McCoy, A. J., Howlett, G. J., Metzger, D. W., et al. (1997) · Protein Engineering Design and Selection · doi:10.1093/protein/10.4.423 · Cited by 133
Evolution of proteins formed by β-sheets
Chothia, C., & Lesk, A. M. (1982) · Journal of Molecular Biology · doi:10.1016/0022-2836(82)90178-4 · Cited by 128
Winter, G. P., & Harris, W. J. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90039-n · Cited by 127
Fed-batch culture of recombinant NS0 myeloma cells with high monoclonal antibody production
Zhou, W., Chen, C.-C., Buckland, B. C., & Aunins, J. G. (1997) · Biotechnology and Bioengineering · doi:10.1002/(sici)1097-0290(19970905)55:5<783::aid-bit8>3.0.co;2-7 · Cited by 125
Nguyen, V. K., HAMERS, R., Wyns, L., & Muyldermans, S. (1999) · Molecular Immunology · doi:10.1016/s0161-5890(99)00067-x · Cited by 123
Production of monoclonal antibodies in COS and CHO cells
Trill, J. J., Shatzman, A. R., & Subinay, G. (1995) · Current Opinion in Biotechnology · doi:10.1016/0958-1669(95)80092-1 · Cited by 120
Poly(lactic acid) nanoparticles labeled with biologically active Neutravidin™ for active targeting
Bossy-Nobs, L., Buchegger, F., Gurny, R., & Allémann, É. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.04.006 · Cited by 117
Cirstoiu-Hapca, A., Bossy-Nobs, L., Buchegger, F., Gurny, R., & Delié, F. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.12.002 · Cited by 116
Immunostimulation Mechanism of LPD Nanoparticle as a Vaccine Carrier
Cui, Z., Han, S., Vangasseri, D. P., & Huang, L. (2004) · Molecular Pharmaceutics · doi:10.1021/mp049907k · Cited by 111
Debin, A., Kravtzoff, R., Santiago, J. V., Cazales, L., Spérandio, S., Melber, K., Janowicz, Z. A., Betbeder, D., & Moynier, M. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00191-3 · Cited by 108
Targeted PARACEST nanoparticle contrast agent for the detection of fibrin
Winter, P. M., Cai, K., Chen, J., Adair, C. R., Kiefer, G. E., Athey, P. S., Gaffney, P. J., Buff, C. E., Robertson, J. D., Caruthers, S. D., et al. (2006) · Magnetic Resonance in Medicine · doi:10.1002/mrm.21093 · Cited by 105
Ligand-Targeted Delivery of Therapeutic siRNA
Ikeda, Y., & Taira, K. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9001-x · Cited by 102
Liu, B., Conrad, F., Cooperberg, M. R., Kirpotin, D. B., & Marks, J. D. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2732 · Cited by 102
Baer, A. E., Laursen, T. A., Guilak, F., & Setton, L. A. (2003) · Journal of Biomechanical Engineering · doi:10.1115/1.1532790 · Cited by 100
The Structural Basis for Antibody Complementary
Kabat, E. A. (1978) · Advances in protein chemistry · doi:10.1016/s0065-3233(08)60574-4 · Cited by 100
Lamalle-Bernard, D., Munier, S., Compagnon, C., Charles, M., Kalyanaraman, V. S., Delair, T., Verrier, B., & Ataman‐Önal, Y. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.07.006 · Cited by 98
Bossy-Nobs, L., Buchegger, F., Gurny, R., & Allémann, É. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00542-2 · Cited by 98
Gupta, B., & Torchilin, V. P. (2007) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-006-0273-0 · Cited by 97
Preparation of inert magnetic nano-particles for the directed immobilization of antibodies
Fuentes, M., Mateo, C., Guisan, J. M., & Fernández‐Lafuente, R. (2004) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2004.06.004 · Cited by 97
Effect of the photocatalytic activity of TiO2 on plasmid DNA
Ashikaga, T., Wada, M., Kobayashi, H., Mori, M., Katsumura, Y., Fukui, H., Shinobu, K. A. T. O., Yamaguchi, M., & Takamatsu, T. (2000) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/s1383-5718(99)00228-4 · Cited by 93
Wang, X., Uto, T., Akagi, T., Akashi, M., & Baba, M. (2007) · Journal of Medical Virology · doi:10.1002/jmv.21029 · Cited by 91
Suwa, T., Ozawa, S., Ueda, M., Ando, N., & Kitajima, M. (1998) · International Journal of Cancer · Cited by 88
Newman, R., Alberts, J., Anderson, D. R., Carner, K., Heard, C., Norton, F. L., Raab, R., Reff, M. E., Shuey, S., & Hanna, N. (1992) · Nature Biotechnology · doi:10.1038/nbt1192-1455 · Cited by 87
Wu, L., Chen, J., Du, D., & Ju, H. (2005) · Electrochimica Acta · doi:10.1016/j.electacta.2005.06.011 · Cited by 87
In Vitro Antibodies: Strategies for Production and Application
Morrison, S. L. (1992) · Annual Review of Immunology · doi:10.1146/annurev.iy.10.040192.001323 · Cited by 83
Mammalian cell expression of dimeric small immune proteins (SIP)
Li, E., Pedraza, A., Bestagno, M., Mancardi, S., Sanchez, R., & Burrone, Ó. R. (1997) · Protein Engineering Design and Selection · doi:10.1093/protein/10.6.731 · Cited by 78
Does endogenous glycosylation prevent the use of mouse monoclonal antibodies as cancer therapeutics?
Borrebaeck, C. A. K., Malmborg, A., & Ohlin, M. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90259-n · Cited by 77
Genospheres: self-assembling nucleic acid-lipid nanoparticles suitable for targeted gene delivery
Hayes, M. E., Drummond, D. C., Kirpotin, D. B., Zheng, W. W., Noble, C. O., Park, J. W., Marks, J. D., Benz, C. C., & Hong, K. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302699 · Cited by 77
Fujita, M., Lee, B., Khazenzon, N. M., Penichet, M. L., Wawrowsky, K., Patil, R., Ding, H., Holler, E., Black, K. L., & Ljubimova, J. Y. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.05.032 · Cited by 77
Mayer, A., Tsiompanou, E., O'Malley, D., Boxer, G., Bhatia, J., Flynn, A. A., Chester, K. A., Davidson, B. R., Lewis, A. A. M., Winslet, M. C., et al. (2000) · PubMed · Cited by 75
Yoo, E. M., Chintalacharuvu, K. R., Penichet, M. L., & Morrison, S. L. (2002) · Journal of Immunological Methods · doi:10.1016/s0022-1759(01)00559-2 · Cited by 69
Production of human antibody repertoires in transgenic mice
Brüggemann, M., & Taussig, M. (1997) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(97)80068-7 · Cited by 67
Ding, Y., Liu, J., Jin, X., Lü, H., Shen, G., & Yu, R. (2007) · The Analyst · doi:10.1039/b713824e · Cited by 64
Development of Multivalent Radioimmunonanoparticles for Cancer Imaging and Therapy
Natarajan, A., Xiong, C., Gruettner, C., DeNardo, G. L., & DeNardo, S. J. (2008) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2007.0410 · Cited by 58
Tsagkogeorgas, F., Ochsenkühn-Petropoulou, M. T., Nießner, R., & Knopp, D. (2006) · Analytica Chimica Acta · doi:10.1016/j.aca.2006.03.006 · Cited by 53
Joralemon, M. J., Smith, N. L., Holowka, D., Baird, B. A., & Wooley, K. L. (2005) · Bioconjugate Chemistry · doi:10.1021/bc0501505 · Cited by 48
Tang, D., Yuan, R., & Chai, Y. (2006) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2006.04.031 · Cited by 48
Humanisation of monoclonal antibodies for therapy.
Gorman, S. D., & Clark, M. (1990) · PubMed · Cited by 47
Kou, G., Gao, J., Wang, H., Chen, H., Li, B., Zhang, D., Wang, S., Hou, S., Qian, W., Dai, J., et al. (2007) · BMB Reports · doi:10.5483/bmbrep.2007.40.5.731 · Cited by 45
Scott, C. J., Marouf, W. M., Quinn, D. J., Buick, R. J., Orr, S. J., Donnelly, R. F., & McCarron, P. A. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9400-7 · Cited by 43
JJroducing antibodies in Escherichia coli: from PCR to fermentation
Plückthun, A., Krebber, A., Krebber, C., Horn, U., Knüpfer, U., Wenderoth, R., Nieba, L., Proba, K., & Riesenberg, D. (1996) · doi:10.1093/oso/9780199635924.003.0010 · Cited by 43
Comparative Pharmacodynamics of Keliximab and Clenoliximab in Transgenic Mice Bearing Human CD4
Sharma, A., Davis, C. B., Tobia, L. A. P., Kwok, D. C., Tucci, M. G., Gore, E. R., Herzyk, D. J., & Hart, T. K. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39200-6 · Cited by 42
Tramontano, A. L., Bianchi, E., Venturini, S., Martin, F., Pessi, A., & Sallozzo, M. (1994) · Journal of Molecular Recognition · doi:10.1002/jmr.300070103 · Cited by 32
Antibody-directed therapies for hematological malignancies
Linenberger, M. L. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02278-5 · Cited by 30
Bentley, K., GEWERT, R., & Harris, W. J. (1998) · Hybridoma · doi:10.1089/hyb.1998.17.559 · Cited by 27
Ogino, C., Kanehira, K., Sasai, R., Sonezaki, S., & Shimizu, N. (2007) · Journal of Bioscience and Bioengineering · doi:10.1263/jbb.104.339 · Cited by 25
Magadán, S., Valladares, M., Suárez, E., Sanjuán, I., Molina, A., AYLING, C. M., Davies, S. L., Zou, X., Williams, G. T., Neuberger, M. S., et al. (2002) · BioTechniques · doi:10.2144/02333dd04 · Cited by 24
Self-citationSUAREZ, E., Magadán, S., SANJUAN, I., Valladares, M., MOLINA, A., Gambón, F., Díaz‐Espada, F., & González‐Fernández, Á. (2005) · Molecular Immunology · doi:10.1016/j.molimm.2005.10.015 · Cited by 16
Self-citationImmunochemical characterization of antibody-coated nanoparticles
Velge-Roussel, F., Breton, P., Guillon, X., Lescure, F., Bru, N., Bout, D. T., & Hoebeke, J. (1996) · Cellular and Molecular Life Sciences · doi:10.1007/bf01923993 · Cited by 16
Raub, C. B., Orwin, E. J., & Haskell, R. C. (2005) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/iembs.2004.1403386 · Cited by 14
Tumor-Targeting Nanosystems for The Delivery of siRNA
Aigner, A. M. (2007) · Nanomedicine · doi:10.2217/17435889.2.4.569 · Cited by 4
Valladares, M., Sanjuán, I., Magadán, S., Molina, A., & Gambón, F. (2004) · Cited by 2
Self-citation
Cited by
Various methods of gold nanoparticles (GNPs) conjugation to antibodies
Jazayeri, M. H., Amani, H., Pourfatollah, A. A., Pazoki-Toroudi, H., & Sedighimoghaddam, B. (2016) · Sensing and Bio-Sensing Research · doi:10.1016/j.sbsr.2016.04.002 · Cited by 528
Magnetic particle hyperthermia—a promising tumour therapy?
Dutz, S., & Hergt, R. (2014) · Nanotechnology · doi:10.1088/0957-4484/25/45/452001 · Cited by 525
Sahu, T., Ratre, Y. K., Chauhan, S., Bhaskar, L. V. K. S., Nair, M. P., & Verma, H. K. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102487 · Cited by 487
Magnetic Nanoparticles in Cancer Theranostics
Gobbo, O. L., Sjaastad, K., Radomski, M. W., Volkov, Y., & Prina-Mello, A. (2015) · Theranostics · doi:10.7150/thno.11544 · Cited by 462
Conde, J., Dias, J. T., Grazú, V., Moros, M., Baptista, P. V., & de la Fuente, J. M. (2014) · Frontiers in Chemistry · doi:10.3389/fchem.2014.00048 · Cited by 425
Metadata
- Authors
- Arruebo, M., Valladares, M., & González-Fernández, Á.
- Venue
- Journal of Nanomaterials
- Publisher
- Wiley
- Published
- 2009-01
- Volume
- 2009
- Issue
- 1
- ISSN
- 1687-4110 (ISSN-L)
- 1687-4129
- OpenAlex
- W1974737102
- Cited by
- 331
- References
- 123
- FWCI
- 3.15
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.